(
185
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Advances in allergen immunotherapy I
-
Allergen immunotherapy has a role in the era of biologics (Con&Pro Session: Con)
-
Cutting edge allergen immunotherapy
-
Delving deeper in allergen immunotherapy
-
Flash Talks on allergen immunotherapy
-
Flash talks on allergen Immunotherapy I
-
How to improve compliance of allergen immunotherapy in the clinic?
-
Improving patient care with allergen immunotherapy (AIT): Lessons learned from randomised control trials (RCT) and real world evidence (RWE) studies
-
New Perspectives on Allergen Immunotherapy
-
New Perspectives on Allergen Immunotherapy
-
Practical recommendations on allergen AiT
-
Safety and prediction of allergen immunotherapy
-
Standardisation of Allergen Immunotherapy products and Legal Considerations
Show more Event Resources (11)Show Less-
-
Allergen immunotherapy adverse events in adults with respiratory allergies-data from ADER: An EAACI task force report
-
Allergen immunotherapy for respiratory allergy: quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needs
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations
-
Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
-
Placebo effects in allergen immunotherapy – An EAACI Task Force Position Paper
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper
-
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy
-
Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies – Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology task force
Show more Position Papers (9)Show Less-
Website
Collapse
-
Advances in Allergen Immunotherapy
-
Advances in Allergen Immunotherapy (AIT)
-
Allergen Immunotherapy
-
Allergen Immunotherapy
-
Allergen Immunotherapy
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)
-
Allergen Immunotherapy for the prevention of respiratory allergy
-
Allergen Immunotherapy in the Republic of Kazakhstan
-
Allergen immunotherapy
-
Allergen immunotherapy
-
Allergen immunotherapy (AIT) in pregnancy, focus on the use of carbamylated monomeric allergoid
-
Allergen immunotherapy 01
-
Allergen immunotherapy 02
-
Allergen immunotherapy 03
-
Allergen immunotherapy 04
-
Allergen immunotherapy 05
-
Allergen immunotherapy 06
-
Allergen immunotherapy 07
-
Allergen immunotherapy 08
-
Allergen immunotherapy 1
-
Allergen immunotherapy 2
-
Allergen immunotherapy 3
-
Allergen immunotherapy 4
-
Allergen immunotherapy 5
-
Allergen immunotherapy 6
-
Allergen immunotherapy 7
-
Allergen immunotherapy and Anaphylaxis
-
Allergen immunotherapy and biologicals: when and how
-
Allergen immunotherapy for airway allergy
-
Allergen immunotherapy for allergic disease: Indications and contraindications
-
Allergen immunotherapy for allergic disease: Indications and contraindications
-
Allergen immunotherapy in childhood: setting up the therapeutic goals
-
Allergen immunotherapy in clinical studies
-
Allergen immunotherapy in food allergy, what’s new?
-
Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19
-
Allergen immunotherapy – Basic and clinical perspective
-
Allergen specific IgE is a stronger predictor of remission following Peanut Oral Immunotherapy in children aged 1-10 years
-
Allergen-specific IgE-blocking antibodies in the course of allergen immunotherapy
-
Allergen-specific IgE/IgG4 ratio as biomarker of allergen immunotherapy efficacy in house dust mite-sensitized allergic rhinitis
-
Allergen-specific immunotherapy based on purified and modified Fel d 1 allergen from cat dander
-
Allergy Therapeutics – Subcutaneous allergen immunotherapy – we will rock you
-
Alterations in B cell memory induced by house dust mite allergen immunotherapy
-
Alterations in B cell memory induced by house dust mite allergen immunotherapy
-
Analysis of epinephrine use during peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1 to 3 years
-
Analyzing Factors Influencing Adherence to Classify Adherence Levels in Patients Treated with Allergen Immunotherapy
-
Application of allergen standardization in allergen-specific immunotherapy (AIT)
-
Artificial intelligence and precision immunology: pioneering biomarker discovery in allergen immunotherapy
-
Assessment of Incidence and Onset of Eosinophilic Esophagitis during the clinical development of Peanut (Arachis hypogaea) Allergen Powder-dried non-fat protein for oral immunotherapy
-
Asthma phenotype markers did not affect allergen immunotherapy effectiveness
-
Basophil activation test as a marker of desensitization in Very Low-Dose Multi-Nut Immunotherapy and Very Low-Dose Peanut Oral Immunotherapy
-
Challenges in food allergen immunotherapy
-
Changing Allergen Immunotherapy Practice Profiles in Mexico
-
Clinical and immunological aspects in allergen immunotherapy
-
Clinical outcomes used in allergen immunotherapy in allergic asthma in the era of Data Science
-
Clinical studies on Allergen Immunotherapy with inhaled allergens: optimization and standardization of methodological approaches
-
Clinical studies on allergen immunotherapy with inhaled allergens: optimization and standardization of methodological approaches
-
Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis
-
Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis
-
Coordinated specific IgG2 and IgE responses are associated with high clinical benefit of allergen immunotherapy with 300 IR house dust mite sublingual tablets in a large European cohort
-
Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: PATIENT’S RESULTS
-
Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: DOCTOR’S RESULTS
-
Current knowledge on venom allergen immunotherapy
-
DRAGO Application: Implementing Adherence and to House Dust Mite Allergen Immunotherapy
-
Delving deeper in allergen immunotherapy
-
Development and implementation of an intelligence platform for management of allergen immunotherapy in China
-
Development of a thermosensitive poloxamer formulation designed to provide a controlled release of the active pharmaceutical ingredient in birch pollen allergen immunotherapy
-
Discovering new horizons in allergen immunotherapy
-
Early inflammatory reactions in mice after immunotherapy with an allergen microcrystalline tyrosine adsorbate
-
Effect of Metformin on allergen specific immunotherapy
-
Effect of Metformin on allergen specific immunotherapy
-
Effect of allergen – specific immunotherapy on PFS symptoms
-
Effect of allergen immunotherapy on quality of life
-
Effect of allergen specific immunotherapy on PFS symptoms
-
Effect of allergen specific immunotherapy on PFS symptoms
-
Effectiveness of House Dust Mite Subcutaneous Immunotherapy on Co-existing Allergen Symptoms in Polysensitized Patients with Allergic Rhinitis: A Multicenter Retrospective Analysis
-
Effectiveness of allergy immunotherapy on asthma medication use and asthma exacerbations: Results from the Real world Evidence of aLlergy immunotherapY (RELY) study
-
Effectiveness of allergy immunotherapy on symptom-relieving medication use: Results from the Real world Evidence of aLlergy immunotherapY (RELY) study
-
Efficacy and safety of allergen immunotherapy in clinical practice
-
Enhanced Symptom Assessment Accuracy: Allergen Exposure Chambers vs. Nasal Allergen Challenges for Timothy Grass Pollen-Induced Allergic Rhinitis
-
Epicutaneous food allergen immunotherapy
-
Evaluation of Patients with Venom Immunotherapy Indication When Immunotherapy Preparation Could Not Be Obtained
-
Evaluation of a new Multiplex Allergen Test Kit for the simultaneous detection of allergen specific IgE
-
Exposure-adjusted safety of peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1-3 years (POSEIDON trial)
-
Factors associated with higher serum IgG4 response in children treated with allergen immunotherapy
-
Flash talks on Allergen Immunotherapy 1
-
Flash talks on Allergen Immunotherapy 2
-
Flash talks on Allergen Immunotherapy 3
-
Flash talks on Allergen Immunotherapy 4
-
Follow up cases of subcutaneous allergen Immunotherapy in respiratory allergic diseases continuing for 10-30years “A Real life experience of 14 cases”
-
How allergists around the world perceive innovation in the context of allergen Immunotherapy AIT: an international survey
-
How effective and safe venom allergen immunotherapy is in children
-
ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy
-
IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
-
IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
-
Immunotherapy-induced neutralising antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy
-
Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy
-
Impact of Security Measures Implementation in Subcutaneous Allergen Immunotherapy Administration at a Pediatric Hospital in Mexico
-
Impact of subcutaneous allergen immunotherapy on autoimmune disease development or exacerbations: a cross-sectional study
-
Impact of subcutaneous allergen immunotherapy on autoimmune disease development or exacerbations: a cross-sectional study
-
Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units
-
Intralymphatic immunotherapy with aluminium hydroxide based grass allergen reduced medication use in patients with allergic rhinoconjunctivitis: a double-blind randomized placebo-controlled trial
-
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma
-
Mapping the Patient’s Journey Prior to Allergen Immunotherapy
-
Microneedles-based transdermal allergen specific immunotherapy protects against gliadin induced anaphylaxis in a mouse model
-
Modulation of B cell memory responses by house dust mite allergen immunotherapy
-
New insights on allergen immunotherapy
-
Novel allergen immunotherapy strategies
-
Online Education Increases Clinician Knowledge and Confidence in Utilizing Allergen Immunotherapy for Respiratory Allergic Disease
-
Oral immunotherapy decreases expression of pro-inflammatory genes upon re-exposure to allergen in egg allergic children
-
Ovalbumin-loaded nanoparticles for allergen specific immunotherapy
-
Patient preference: A multinational discrete-choice-experiment (DCE) in pollen allergen immunotherapy (AIT)
-
Poloxamer formulation for allergen immunotherapy reduces systemic allergic reactions in a mouse model
-
Positive outcome of the pivotal Phase III study with PQ Grass, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine and Monophosphoryl Lipid A as adjuvant system
-
Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score
-
Present and future of allergen immunotherapy
-
Profiling Allergenic Proteins in Allergen Extracts of the Newly Developed Timothy Grass Allergen Specific IgE Assay on a Fully Automated Chemiluminescence Immunoassay Platform – Autolumo® A2000 Plus
-
Progress in understanding the mechanisms of airborne allergen immunotherapy
-
Prospective, pilot, phase 1 study of iPUMP© in patients starting sublingual allergen immunotherapy (Staloral©)
-
Protein and allergen content variability of peanut-containing products used in oral immunotherapy for peanut allergy
-
Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
-
Real-world allergen immunotherapy effectiveness in allergic asthma
-
Safety Data for House Dust Mite and Pollen Subcutaneous Allergen Immunotherapy in Children: Systemic Reactions and Risk Factors
-
Safety and Tolerability of Rush Updosing Using a Mugwort Allergoid Extract for Subcutaneous Allergen Immunotherapy
-
Safety and tolerability of in-season initiation of subcutaneous and sublingual allergen immunotherapy with SQ grass pollen products: a comprehensive review
-
Safety of 300IR liquid sublingual immunotherapy of cat allergen extract for respiratory allergy to cat dander: a post-marketing experience
-
Safety of allergen immunotherapy in patients with severe asthma. A real-world, multicentre, observational retrospective study
-
Should we be concerned when starting allergen immunotherapy in patients with controlled HIV infection or autoimmune diseases?
-
Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
-
Sublingual allergen immunotherapy in children with AR
-
Sublingual dust mite allergen immunotherapy reduces respiratory infections in children with allergic rhinitis
-
Sustained and Long-term effect of allergen immunotherapy in local respiratory allergy
-
Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis
-
Systemic allergic reactions to subcutaneous allergen immunotherapy – A single center experience
-
TAPAS – a long-term non-interventional study evaluating MCT (MicroCrystalline Tyrosine)-associated allergoids shows non-inferiority of clinical effectiveness in children compared to adults during a 3-year course of allergen immunotherapy
-
The Quest for Tolerance in Allergen Immunotherapy
-
The clinical value of allergen detection panel in Guangzhou, southern China: A big data study based on allergen detection in the past 7 years
-
The journey to registration: challenges for allergen immunotherapy trials
-
Updates in the clinical management of allergen immunotherapy
-
Using the AllergyVax app to increase adherence to allergen subcutaneous immunotherapy
-
Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life
-
Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life
-
“Rhythm of Success”: Sustaining Benefits in Allergen Immunotherapy
-
From allergen molecules to allergy management: can molecular diagnosis improve allergen immunotherapy efficacy?
Show more Sessions (143)Show Less-